Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53

Biochemical and Biophysical Research Communications

Volumn 334, Issue 1, 2005, Pages 223-230

  Hsieh, Tze Chen ^a   Wang, Zhirong ^a   Hamby, Carl V ^a   Wu, Joseph M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Immobilized resveratrol affinity columns; Melanoma carcinogenesis; Resveratrol; Resveratrol targeting protein NQO2

Indexed keywords

PROTEIN P21; PROTEIN P53; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); RESVERATROL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CELL TYPE; CHROMATOGRAPHY; COLONY FORMATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG BINDING; FLOW CYTOMETRY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MELANOMA CELL; METASTASIS; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; UPREGULATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; QUINONE REDUCTASES; STILBENES; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

VITIS SP.;

EID: 22144463236     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.06.073     Document Type: Article

References (43)

1. R. Doll, and R. Peto The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today J. Natl. Cancer Inst. 66 1981 1191 1308
2. C.R. Wolf Chemoprevention: increased potential to bear fruit Proc. Natl. Acad. Sci. USA 98 2001 2941 2943
3. M.B. Sporn, and N. Suh Chemoprevention: an essential approach to controlling cancer Nat. Rev. Cancer 2 2002 537 543
4. V.L. Go, R.R. Butrum, and D.A. Wong Diet, nutrition, and cancer prevention: the postgenomic era J. Nutr. 133 2003 3830S 3836S
5. C.S. Yang, J.M. Landau, M.T. Huang, and H.L. Newmark Inhibition of carcinogenesis by dietary polyphenolic compounds Annu. Rev. Nutr. 21 2001 381 406
6. Y. Kuroda, and Y. Hara Antimutagenic and anticarcinogenic activity of tea polyphenols Mutat. Res. 436 1999 69 97
7. M. Nihal, N. Ahmad, H. Mukhtar, and G.S. Wood Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma Int. J. Cancer 114 2005 513 521
8. S. Caltagirone, C. Rossi, A. Poggi, F.O. Ranelletti, P.G. Natali, M. Brunetti, F.B. Aiello, and M. Piantelli Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential Int. J. Cancer 87 2000 595 600
9. J.A. Milner, S.S. McDonald, D.E. Anderson, and P. Greenwald Molecular targets for nutrients involved with cancer prevention Nutr. Cancer 41 2001 1 16
10. G.J. Soleas, E.P. Diamandis, and D.M. Goldberg Resveratrol: a molecule whose time has come? And gone? Clin. Biochem. 30 1997 91 113
11. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W. Beecher, H.H. Fong, N.R. Farnsworth, A.D. Kinghorn, R.G. Mehta, R.C. Moon, and J.M. Pezzuto Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218 220
12. N.J. Miller, and C.A. Rice-Evans Antioxidant activity of resveratrol in red wine Clin. Chem. 41 1995 1789
13. C. Alarcon de la Lastra, and I. Villegas Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications Mol. Nutr. Food Res. 49 2005 405 430
14. R.H. Liu Potential synergy of phytochemicals in cancer prevention: mechanism of action J. Nutr. 134 2004 3479S 3485S
15. J. Boyer, and R.H. Liu Apple phytochemicals and their health benefits Nutr. J. 3 2004 5
16. L. Fremont Biological effects of resveratrol Life Sci. 66 2000 663 673
17. J.M. Wu, Z.R. Wang, T.C. Hsieh, J.L. Bruder, J.G. Zou, and Y.Z. Huang Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine (Review) Int. J. Mol. Med. 8 2001 3 17
18. F. Bianchini, and H. Vainio Wine and resveratrol: mechanisms of cancer prevention? Eur. J. Cancer Prev. 12 2003 417 425
19. Z. Wang, T.C. Hsieh, Z. Zhang, Y. Ma, and J.M. Wu Identification and purification of resveratrol targeting proteins using immobilized resveratrol affinity chromatography Biochem. Biophys. Res. Commun. 323 2004 743 749
20. L. Buryanovskyy, Y. Fu, M. Boyd, Y. Ma, T.C. Hsieh, J.M. Wu, and Z. Zhang Crystal structure of quinone reductase 2 in complex with resveratrol(.) Biochemistry 43 2004 11417 11426
21. A. Jemal, R.C. Tiwari, T. Murray, A. Ghafoor, A. Samuels, E. Ward, E.J. Feuer, and M.J. Thun Cancer statistics, 2004 CA Cancer J. Clin. 54 2004 8 29
22. H.L. Howe, P.A. Wingo, M.J. Thun, L.A. Ries, H.M. Rosenberg, E.G. Feigal, and B.K. Edwards Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends J. Natl. Cancer Inst. 93 2001 824 842
23. D.S. Rigel, R.J. Friedman, and A.W. Kopf The incidence of malignant melanoma in the United States: issues as we approach the 21st century J. Am. Acad. Dermatol. 34 1996 839 847
24. M.B. Atkins, K.R. O'Boyle, J.A. Sosman, G.R. Weiss, K.A. Margolin, M.L. Ernest, K. Kappler, J.W. Mier, J.A. Sparano, and R.I. Fisher Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanoma J. Clin. Oncol. 12 1994 1553 1560
25. L. Dreiling, S. Hoffman, and W.A. Robinson Melanoma: epidemiology, pathogenesis, and new modes of treatment Adv. Intern. Med. 41 1996 553 604
26. M.B. Atkins The treatment of metastatic melanoma with chemotherapy and biologics Curr. Opin. Oncol. 9 1997 205 213
27. S. F'Guyer, F. Afaq, and H. Mukhtar Photochemoprevention of skin cancer by botanical agents Photodermatol. Photoimmunol. Photomed. 19 2003 56 72
28. M.F. Demierre, and L. Nathanson Chemoprevention of melanoma: an unexplored strategy J. Clin. Oncol. 21 2003 158 165
29. C.V. Hamby, C.E. Mendola, L. Potla, G. Stafford, and J.M. Backer Differential expression and mutation of NME genes in autologous cultured human melanoma cells with different metastatic potentials Biochem. Biophys. Res. Commun. 211 1995 579 585
30. C.V. Hamby, R. Abbi, N. Prasad, C. Stauffer, J. Thomson, C.E. Mendola, V. Sidorov, and J.M. Backer Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells Int. J. Cancer 88 2000 547 553
31. T.C. Hsieh, and J.M. Wu Effects of fenretinide (4-HPR) on prostate LNCaP cell growth, apoptosis, and prostate-specific gene expression Prostate 33 1997 97 104
32. T.C. Hsieh, and J.M. Wu Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines Exp. Cell Res. 249 1999 109 115
33. T.C. Hsieh, and J.W. Chiao Growth modulation of human prostatic cancer cells by interleukin-1 and interleukin-1 receptor antagonist Cancer Lett. 95 1995 119 123
34. T.C. Hsieh, X. Lu, J. Guo, W. Xiong, J. Kunicki, Z. Darzynkiewicz, and J.M. Wu Effects of herbal preparation Equiguard on hormone-responsive and hormone-refractory prostate carcinoma cells: mechanistic studies Int. J. Oncol. 20 2002 681 689
35. A.M. DiPietrantonio, T.C. Hsieh, G. Juan, F. Traganos, Z. Darzynkiewicz, and J.M. Wu Fenretinide-induced caspase 3 activity involves increased protein stability in a mechanism distinct from reactive oxygen species elevation Cancer Res. 60 2000 4331 4335
36. R. Lu, and G. Serrero Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells J. Cell. Physiol. 179 1999 297 304
37. O.P. Mgbonyebi, J. Russo, and I.H. Russo Antiproliferative effect of synthetic resveratrol on human breast epithelial cells Int. J. Oncol. 12 1998 865 869
38. S.H. Mitchell, W. Zhu, and C.Y. Young Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells Cancer Res. 59 1999 5892 5895
39. R.M. Niles, M. McFarland, M.B. Weimer, A. Redkar, Y.M. Fu, and G.G. Meadows Resveratrol is a potent inducer of apoptosis in human melanoma cells Cancer Lett. 190 2003 157 163
40. S. Yang, and F.L. Meyskens Jr. Alterations in activating protein 1 composition correlate with phenotypic differentiation changes induced by resveratrol in human melanoma Mol. Pharmacol. 67 2005 298 308
41. M. Fontecave, M. Lepoivre, E. Elleingand, C. Gerez, and O. Guittet Resveratrol, a remarkable inhibitor of ribonucleotide reductase FEBS Lett. 421 1998 277 279
42. L.A. Stivala, M. Savio, F. Carafoli, P. Perucca, L. Bianchi, G. Maga, L. Forti, U.M. Pagnoni, A. Albini, E. Prosperi, and V. Vannini Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol J. Biol. Chem. 276 2001 22586 22594
43. K. Iskander, M. Paquet, C. Brayton, and A.K. Jaiswal Deficiency of NRH:quinone oxidoreductase 2 increases susceptibility to 7,12-dimethylbenz(a) anthracene and benzo(a)pyrene-induced skin carcinogenesis Cancer Res. 64 2004 5925 5928